Nasulin intranasal insulin: Preliminary Phase IIa data

Preliminary data from a double-blind, U.S. Phase IIa trial in 94 patients showed that inhaled Nasulin in combination with basal insulin and oral diabetes agents missed

Read the full 264 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE